Healthcare & Medical Devices Global On demand · 24-48h

Global Buccal Swab Collection Kit Market Strategic Research Report

Global Buccal Swab Collection Kit Market Strategic Research …
$3,500 USD
Market Research Reports
Strategic Research Report
Global Buccal Swab Collection Kit Market
$2832025
4.7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Single-Swab Type, Double-Swab Type, Others

By Application: Clinical Diagnosis, Life Science Research, Forensic Analysis, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Thermo Fisher Scientific, QIAGEN, Cell Projects, Mawi DNA Technologies, Norgen Biotek Corp., Invitek Diagnostics, Zymo Research Corporation, COPAN Italia, Sedia Biosciences, Canvax Biotech, Sirchie, Bode Technology, Tri-Tech Forensics, SceneSafe, EVIDENT, Mantacc, Huachenyang, Shenzhen Medico Technology, Mandelab

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 145 pages
Market size 2025
$283
Million USD
Forecast CAGR
4.7%
2025-2032
Forecast 2032
$390.3
Projected
Regiões
5
Asia Pacific · Latin America · MEA · Europe · North America

Visão geral

Scope of the Report

The global Buccal Swab Collection Kit market size is predicted to grow from US$ 283 million in 2025 to US$ 401 million in 2032; it is expected to grow at a CAGR of 4.7% from 2026 to 2032.

In 2025, global Buccal Swab Collection Kit production reached approximately 114,583 k units,with an average global market price of around US$ 2.4 per unit, and a gross profit margin of approximately 20%-40%. A buccal swab collection kit is a single-use pre-analytical system designed to collect epithelial cells, saliva residues and associated biological material from the inner cheek. A typical kit contains one or more sterile cotton, foam, polyester or nylon-flocked swabs, together with a collection tube, drying pouch, preservation solution or transport envelope. Labels, barcodes, instructions, gloves, desiccants and tamper-evident seals may also be included. By standardizing collection, preservation and transportation, the kit reduces contamination, microbial growth and nucleic-acid degradation before laboratory processing. Buccal specimens are principally used to obtain human genomic DNA, although specialized products may preserve RNA, microbial nucleic acids, proteins or intact cells. The collected material can subsequently support PCR, STR profiling, microarrays, sequencing and other molecular analyses. The definition excludes DNA extraction reagents, analytical instruments, testing services, funnel-based saliva collectors and swabs intended exclusively for nasal, nasopharyngeal or throat sampling.

The upstream segment supplies medical-grade cotton, rayon, polyester, polyurethane foam, flocked nylon fiber, polypropylene or ABS shafts, molded tubes, preservation reagents, desiccants, treated collection cards, labels and tamper-evident packaging. Supporting activities include injection molding, fiber flocking, adhesive formulation, reagent filling, irradiation or ethylene-oxide sterilization and DNA-decontaminated packaging. Midstream manufacturers design the swab geometry, collection matrix and preservation format; assemble swabs with tubes, envelopes, cards or stabilizing media; and conduct sterility, nuclease-free, human-DNA-free, recovery, stability, leakage and packaging-integrity validation. Specialist companies also provide private-label and OEM kits for genetic laboratories, forensic agencies and diagnostic companies. Downstream customers include hospitals, molecular diagnostic laboratories, forensic laboratories, police agencies, genetic testing providers, pharmaceutical companies, CROs, biobanks and academic institutions. Collected specimens enter extraction, direct-PCR, genotyping, STR profiling, microarray or sequencing workflows. Industry value increasingly depends on consistent cellular yield, ambient-temperature stability, contamination control, sample traceability, self-collection usability and compatibility with automated laboratory systems.

This report presents a comprehensive overview of the global Buccal Swab Collection Kit market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Single-Swab Type
  • Double-Swab Type
  • Others

Segment by Tip Material

  • Medical cotton
  • Viscose fiber
  • Polyurethane foam
  • Others

Segment by Application

  • Clinical Diagnosis
  • Life Science Research
  • Forensic Analysis
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Buccal Swab Collection Kit market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Clinical Diagnosis, Life Science Research, Forensic Analysis evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Buccal Swab Collection Kit Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 4.7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$283
2025
Forecast
$390.3
2032
CAGR
4.7%
2025–2032
Regiões
5
global
Key companies
Thermo Fisher ScientificQIAGENCell ProjectsMawi DNA TechnologiesNorgen Biotek Corp.Invitek DiagnosticsZymo Research CorporationCOPAN Italia
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Single-Swab TypeDouble-Swab TypeOthers
By Application
Clinical DiagnosisLife Science ResearchForensic AnalysisOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Single-Swab Type
  • 3.1.3 Double-Swab Type
  • 3.1.4 Others
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Clinical Diagnosis
  • 4.1.3 Life Science Research
  • 4.1.4 Forensic Analysis
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Thermo Fisher Scientific
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 QIAGEN
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Cell Projects
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Mawi DNA Technologies
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Norgen Biotek Corp.
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Invitek Diagnostics
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Zymo Research Corporation
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 COPAN Italia
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Sedia Biosciences
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Canvax Biotech
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Sirchie
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Bode Technology
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Tri-Tech Forensics
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 SceneSafe
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 EVIDENT
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Mantacc
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Huachenyang
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Shenzhen Medico Technology
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Mandelab
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Buccal Swab Collection Kit market?
The global Buccal Swab Collection Kit market is estimated at US$ 283 million in 2025 (base year) and is projected to reach US$ 401 million by 2032.
How fast is the Buccal Swab Collection Kit market expected to grow?
The market is expected to grow at a CAGR of 4.7% from 2026 to 2032, expanding from US$ 283 million in 2025 to US$ 401 million in 2032, roughly 1.4 times its base-year value.
What does the Buccal Swab Collection Kit market cover?
In 2025, global Buccal Swab Collection Kit production reached approximately 114,583 k units,with an average global market price of around US$ 2.4 per unit, and a gross profit margin of approximately 20%-40%. A buccal swab collection kit is a single-use pre-analytical system designed to collect epithelial cells, saliva residues and associated biological material from the inner cheek.
What are the main segments of the Buccal Swab Collection Kit market by type?
By type, the market is segmented into Single-Swab Type, Double-Swab Type and Others.
Which applications drive demand in the Buccal Swab Collection Kit market?
Key applications covered include Clinical Diagnosis, Life Science Research, Forensic Analysis and Others.
Who are the key players in the Buccal Swab Collection Kit market?
Key players profiled include Thermo Fisher Scientific, QIAGEN, Cell Projects, Mawi DNA Technologies, Norgen Biotek Corp., Invitek Diagnostics, Zymo Research Corporation and COPAN Italia, among 19 companies covered in total.
Which regions and countries are covered for Buccal Swab Collection Kit?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Buccal Swab Collection Kit market report?
The report is intended for manufacturers and solution providers, distributors and end users in Clinical Diagnosis, Life Science Research and Forensic Analysis, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Buccal Swab Collection Kit market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.